A blood pressure medication is being recalled after a patient complained about receiving a lower dose.
Crescent Pharma Limited issued the precautionary recall on April 20 over a “potential manufacturing error”.
It was sent to patients, pharmacies and wholesalers for Ramipril 10mg capsules, from a batch first distributed in May .
Read more: Blood pressure medication recalled after pharmacy complaint
A blister pack of Ramipril 5mg capsules were found in the 10mg carton by a patient, which may mean some other cartons also contain the lower dose.
The manufacturer said the error appears to have taken place during secondary packaging of the cartons at the same manufacturing site for both medications.
All packs from the affected Ramipril 10mg batch number GR174091 have been recalled, and pharmacy professionals have been told to stop supplying the affected medication and return any remaining stock to suppliers.
Read more: Toxin poisoning in 36 children after infant formula recalls
They have also been told to contact all patients who have been dispensed the medication to return it.
The Medicines and Healthcare products Regulatory Agency (MHRA) told patients to get medical advice if experiencing any “adverse” effects.
But it added the risk of taking the lower dose “for a limited time is very low” and any possible impact from it is “expected to be gradual rather than immediate or life threatening”.
Read more: MHRA issues alert after pharmacy robot spots drug barcode error
MHRA chief safety officer Dr Alison Cave said patients should contact their dispensing pharmacy if they find any 5mg capsules in a 10mg carton.
It follows Crescent Pharma Limited issuing a precautionary recall of one batch of Ramipril 5 mg capsules in March after a pharmacy alerted the MHRA to an error.
And the UK Health Security Agency announced in February that some 36 children have been reported as having symptoms of poisoning after infant and follow-on formulas were recalled over potential toxin contaminations.
